Dana-Farber Team Develops Open-Access Predictive Tool to Improve Monitoring of Smoldering Multiple Myeloma

The tool, called PANGEA-SMM, outperforms existing predictive tools by more accurately determining when smoldering multiple myeloma is progressing and requires treatment. The free online tool can be used immediately to monitor patients.

By
March 24, 2026
5 min

Dana-Farber

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

#1

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Hematology
- Oncology
- Cancer Research
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Hematology
- Oncology
- Cancer Research
#3

Mayo Clinic

Rochester, MN
Key Differentiators
- Hematology
- Oncology
- Cancer Research
#4

Johns Hopkins Medicine

Baltimore, MD
Key Differentiators
- Hematology
- Oncology
- Cancer Research
#5

University of Arkansas for Medical Sciences

Little Rock, AR
Key Differentiators
- Hematology
- Oncology
- Cancer Research

Dana-Farber Team Develops Open-Access Predictive Tool to Improve Monitoring of Smoldering Multiple Myeloma

Top Institutions in Hematology

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Mayo Clinic

Johns Hopkins Medicine

University of Arkansas for Medical Sciences

Original Source(s)

Dana-Farber Team Develops Open-Access Predictive Tool to Improve Monitoring of Smoldering Multiple Myeloma

Related Content

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Computed tomography-derived sarcopenia, enteral nutritional support, and febrile neutropenia burden in children with acute lymphoblastic leukemia: a retrospective cohort study

The very rare association between T-cell acute lymphoblastic leukemia and down syndrome: a case report and review of the literature